191 related articles for article (PubMed ID: 19968782)
1. Atrophy of mesenteric sympathetic innervation may contribute to splanchnic vasodilation in rat portal hypertension.
Coll M; Martell M; Raurell I; Ezkurdia N; Cuenca S; Hernández-Losa J; Esteban R; Guardia J; Bosch J; Genescà J
Liver Int; 2010 Apr; 30(4):593-602. PubMed ID: 19968782
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of genes related to the adrenergic system may contribute to splanchnic vasodilation in rat portal hypertension.
Coll M; Genescà J; Raurell I; Rodríguez-Vilarrupla A; Mejías M; Otero T; Oria M; Esteban R; Guardia J; Bosch J; Martell M
J Hepatol; 2008 Jul; 49(1):43-51. PubMed ID: 18457899
[TBL] [Abstract][Full Text] [Related]
3. Blockage of the afferent sensitive pathway prevents sympathetic atrophy and hemodynamic alterations in rat portal hypertension.
Ezkurdia N; Coll M; Raurell I; Rodriguez S; Cuenca S; González A; Guardia J; Esteban R; Genescà J; Martell M
Liver Int; 2012 Sep; 32(8):1295-305. PubMed ID: 22292477
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of nNOS and associated increase in nitrergic vasodilation in superior mesenteric arteries in pre-hepatic portal hypertension.
Jurzik L; Froh M; Straub RH; Schölmerich J; Wiest R
J Hepatol; 2005 Aug; 43(2):258-65. PubMed ID: 15963596
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertension.
Wiest R; Jurzik L; Moleda L; Froh M; Schnabl B; von Hörsten S; Schölmerich J; Straub RH
J Hepatol; 2006 Mar; 44(3):512-9. PubMed ID: 16324766
[TBL] [Abstract][Full Text] [Related]
6. Restriction of drinking water abrogates splanchnic vasodilation and portal hypertension in portal vein-ligated rats.
Heinemann A; Schuligoi R; Lippe IT; Stauber RE
Pharmacology; 2009; 83(1):26-32. PubMed ID: 18987488
[TBL] [Abstract][Full Text] [Related]
7. Alterations in mechanical properties of mesenteric resistance arteries in experimental portal hypertension.
Resch M; Wiest R; Moleda L; Fredersdorf S; Stoelcker B; Schroeder JA; Schölmerich J; Endemann DH
Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G849-57. PubMed ID: 19696142
[TBL] [Abstract][Full Text] [Related]
8. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
[TBL] [Abstract][Full Text] [Related]
9. Enhanced cyclooxygenase-1 expression within the superior mesenteric artery of portal hypertensive rats: role in the hyperdynamic circulation.
Hou MC; Cahill PA; Zhang S; Wang YN; Hendrickson RJ; Redmond EM; Sitzmann JV
Hepatology; 1998 Jan; 27(1):20-7. PubMed ID: 9425912
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.
Moleda L; Trebicka J; Dietrich P; Gäbele E; Hellerbrand C; Straub RH; Sauerbruch T; Schoelmerich J; Wiest R
Gut; 2011 Aug; 60(8):1122-32. PubMed ID: 21317421
[TBL] [Abstract][Full Text] [Related]
11. Does local sympathetic atrophy contribute to splanchnic vasodilation in portal hypertension?
Møller S; Stauber RE
Liver Int; 2010 Apr; 30(4):499-501. PubMed ID: 20158609
[No Abstract] [Full Text] [Related]
12. Neuropeptide Y restores non-receptor-mediated vasoconstrictive action in superior mesenteric arteries in portal hypertension.
Hartl J; Dietrich P; Moleda L; Müller-Schilling M; Wiest R
Liver Int; 2015 Dec; 35(12):2556-63. PubMed ID: 26010514
[TBL] [Abstract][Full Text] [Related]
13. Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats.
Coll M; Rodriguez S; Raurell I; Ezkurdia N; Brull A; Augustin S; Guardia J; Esteban R; Martell M; Genescà J
Hepatology; 2012 Nov; 56(5):1849-60. PubMed ID: 22610782
[TBL] [Abstract][Full Text] [Related]
14. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
Reiberger T; Payer BA; Schwabl P; Hayden H; Horvatits T; Jäger B; Hummel T; Mitterhauser M; Trauner M; Fuhrmann V; Angermayr B; Peck-Radosavljevic M;
Liver Int; 2013 Apr; 33(4):561-8. PubMed ID: 23331709
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats.
Huang HC; Wang SS; Hsin IF; Chang CC; Lee FY; Lin HC; Chuang CL; Lee JY; Hsieh HG; Lee SD
Hepatology; 2012 Jul; 56(1):248-58. PubMed ID: 22290687
[TBL] [Abstract][Full Text] [Related]
16. Expression of cyclooxygenase in hyperdynamic portal hypertensive rats.
Cao H; Xu J; Hua R; Meng FB; Qiu JF; Wu ZY
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):252-6. PubMed ID: 16698586
[TBL] [Abstract][Full Text] [Related]
17. Vasopressin reverses mesenteric hyperemia and vasoconstrictor hyporesponsiveness in anesthetized portal hypertensive rats.
Heinemann A; Wachter CH; Fickert P; Trauner M; Stauber RE
Hepatology; 1998 Sep; 28(3):646-54. PubMed ID: 9731553
[TBL] [Abstract][Full Text] [Related]
18. Mesenteric vasoconstriction triggers nitric oxide overproduction in the superior mesenteric artery of portal hypertensive rats.
Tsai MH; Iwakiri Y; Cadelina G; Sessa WC; Groszmann RJ
Gastroenterology; 2003 Nov; 125(5):1452-61. PubMed ID: 14598261
[TBL] [Abstract][Full Text] [Related]
19. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
[TBL] [Abstract][Full Text] [Related]
20. Increased angiogenesis in portal hypertensive rats: role of nitric oxide.
Sumanovski LT; Battegay E; Stumm M; van der Kooij M; Sieber CC
Hepatology; 1999 Apr; 29(4):1044-9. PubMed ID: 10094944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
